Illumina's Q1 2026 Earnings: Strong Start, Potential Turnaround

Illuminas Q1 2026 earnings exceeded Wall Street expectations, with revenue surging 4.8% to $1.09 billion and adjusted EPS soaring 9% to $1.15. Full-year guidance was raised, and operating margins improved. Despite sluggish growth over the past five years, this quarters beat suggests a potential turnaround. Shares dipped slightly, but CEO Jacob Thaysen remains optimistic about Illuminas genomics ecosystem. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/99f060c2608ba59d